Citations

Clear

17 citation(s) found for "Smith, Emily R".

Global Barriers to Otolaryngology Care
Patterson, Rolvix H. , Bangash, Ali Haider , Pandey, Akansha, Elwell, Zachary , Adeyemo, Adebolajo A. , Cahill, Gabrielle , Cherches, Alexander , Daudu, Davina , Der, Carolina , Din, Taseer , Hapunda, Racheal , Ibekwe, Titus , Maina, Ivy W. , Mukuzi, Allan, Nakku, Doreen , Petrucci, Beatriz, Pietrobon, Carolina, Salano, Valerie , Sprow, Holly N. , Waterworth, Christopher J. , Wiedermann, Joshua P. , Xu, Mary Jue , Alkire, Blake C., Okerosi, Samuel , Initiative, Global Otolaryngology–Head and Neck Surgery, Bhutta, Mahmood F. , Dillard, Lauren K. , Ncogoza, Isaie , Lin, H.C., Potent, Keith, Adel, Iman, Wiedermann, Joshua , Cherches, Alexander D , Din, Taseer , Ncogoza, Isaie , Bangash, Ali Haider , Patterson, Rolvix H , Zalaquett, Nader , Pandey, Akansha, Nuss, Sarah , Fei‐Zhang, David J. , Srinivasan, Tarika , Fagan, Johannes J. , Kahinga, Aveline Aloyce , Seguya, Amina , Shaye, David , Smith, Emily R. , Tamir, Sharon Ovnat , Wen, Christopher Z. , Initiative, Global Otolaryngology–Head and Neck Surgery, Shah, Keshav V. , Potent, Keith

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | April 24, 2025 | Volume: 151 | Issue: 6 | Pages: 604

10.1001/jamaoto.2025.0573 | PMID 40272811 Get It

ImportanceUnderstanding the global barriers to otolaryngology–head and neck surgery (OHNS) care is crucial in addressing disparities in access to care, particularly in low-income and middle-income countries (LMICs).ObjectiveTo characterize barriers to comprehensive otolaryngology care across World Bank income groups.Design, Setting, and ParticipantsUsing an online cross-sectional survey that was administered by the Global OHNS Initiative via international and national professional societies, personal contacts, and social media, this study captured the perceptions of otolaryngologists regarding barriers to OHNS care at the levels of the country, health sector, clinician, and patient. Participants included otolaryngologists from the 194 World Health Organization member states and Taiwan. Eligibility criteria included a medical degree and specialized training in managing conditions of the ear, nose, and throat. The nonresponse rate was not recorded. The data collection period spanned from October 2022 to June 2023.ExposuresExposures included World Bank income group classification.Main Outcomes and MeasuresThe primary outcomes were Likert scale responses regarding frequency of barriers to OHNS care. The a priori hypothesis was that LMICs would report more frequent barriers to OHNS care.ResultsThe study involved 146 otolaryngologists (47 female individuals [32%]), with 69 (47%) from high-income countries and 77 (53%) from LMICs. Male individuals represented 45 high-income country respondents (65%) and 54 LMIC respondents (70%). Barriers were reported across income groups at all levels of the health system, with a higher frequency in LMICs. Several barriers were reported to be more substantial in LMICs, such as the national volume and distribution of otolaryngologists, financial compensation for clinicians, and patient stigma, and others were common across income settings, such as the availability of operating rooms and inflexible working hours. Common concerns included national and health sector barriers: OHNS workforce, referral networks, government support; clinician barriers: excessive clinician workloads, understaffing, poor administration support; patient barriers: distance to health care facilities, financial burdens such as medical costs and foregone wages, stigma, and health literacy.Conclusions and RelevanceThe results of this cross-sectional study suggest that there are barriers to otolaryngology care globally that affected all levels of the health care system. This work may inform prioritization of otolaryngology within research and policy, and it emphasizes the need for effective strategies to expand access to otolaryngology care, particularly in lower-income settings.
Otolaryngology–Head and Neck Surgery Training and Service Delivery: An International Survey
Nuss, Sarah , Nakku, Doreen , Pandey, Akansha, Elwell, Zachary , Fei‐Zhang, David J. , Srinivasan, Tarika , Patterson, Rolvix H. , Adeyemo, Adebolajo A. , Cherches, Alexander , Bangash, Ali Haider , Mukuzi, Allan, Petrucci, Beatriz, Mussa, Carolina Der, Pietrobon, Carolina, Waterworth, Christopher J. , Daudu, Davina , Cahill, Gabrielle , Sprow, Holly N. , Maina, Ivy W. , Wiedermann, Joshua P. , Xu, Mary Jue , Thapa, Nar Maya, Hapunda, Racheal , Okerosi, Samuel , Ibekwe, Titus , Alkire, Blake C., Salano, Valerie , Din, Taseer , Initiative, Global OHNS, Fei-Zhang, David , Fagan, Johannes J , Wiedermann, Joshua , Tamir, Sharon Ovnat , Cherches, Alexander D , Din, Taseer , Bangash, Ali Haider , Patterson, Rolvix H , Pandey, Akansha, Seguya, Amina , Kahinga, Aveline Aloyce , Mussa, Carolina Der, Shaye, David , Smith, Emily R. , Fagan, Johannes J. , Zalaquett, Nader , Thapa, Nar Maya, Initiative, Global OHNS

Mayo Clinic

Laryngoscope Investigative Otolaryngology | February 14, 2025 | Volume: 10 | Issue: 1 | Pages: No page available

10.1002/lio2.70096 | PMID 39958946 Get It

ABSTRACTImportanceHighlighting the global disparities in otolaryngology training and, ultimately, service delivery, emphasizing the need for equitable access to training resources and programs.ObjectiveTo describe the relationship between the quality, content, and location of otolaryngology–head and neck surgery training and education and the resulting impact on the delivery of otolaryngology care globally.DesignAn online cross‐sectional survey to otolaryngologists, gathering information on their training and education experiences, and factors influencing their choice of training location and practice.SettingThe online survey was available in multiple languages, distributed via national and international professional otolaryngology societies, snowballing and social media.ParticipantsThe respondents were practicing otolaryngologists representing all seven World Health Organization regions.ExposuresWorld Bank income groups classification.Main Outcomes and MeasuresOur expected outcome was that subspecialty training and access to educational resources were significantly readily available to respondents from high‐income countries, leading to more confidence in performing complex procedures post training.ResultsA total of 91 participants were included in the analysis, with 47 (52%) practicing in high‐income countries and 44 (48%) in low‐ and middle‐income countries. Sixty‐one participants (67%) were male. Subspecialty training and access to educational resources were significantly less available in low‐ and middle‐income countries, leading to lower confidence among low‐ and middle‐income countries physicians in performing complex procedures. High‐income country respondents reported better access to diverse training resources and felt more prepared for a broader range of procedures.Conclusion and RelevanceSignificant disparities exist in OHNS training resources and subspecialty training opportunities between high‐ and low‐middle‐income countries. There is a critical need to integrate complementary training and educational modalities into local systems. Addressing the shortage of educational resources and promoting open‐access initiatives in low‐middle‐income countries are essential steps toward enhancing surgical education and improving global otolaryngology healthcare outcomes.
Essential Equipment for Baseline Otolaryngology‐Head and Neck Surgery Care: A Global Cross‐Sectional Survey
Srinivasan, Tarika , Cherches, Alexander , Pandey, Akansha, Fei‐Zhang, David J. , Elwell, Zachary , Adeyemo, Adebolajo A. , Alkire, Blake C., Bangash, Ali Haider , Cahill, Gabrielle , Daudu, Davina , Mussa, Carolina Der, Din, Taseer , Hapunda, Racheal , Ibekwe, Titus , Maina, Ivy W. , Mukuzi, Allan, Patterson, Rolvix H. , Sprow, Holly N. , Waterworth, Christopher J. , Wiedermann, Joshua P. , Xu, Mary Jue , Initiative, Global OHNS, Fei-Zhang, David , Bangash, Ali Haider , Fagan, Johannes J , Patterson, Rolvix H , Shaye, David , Xu, Mary Jue , Kahinga, Aveline Aloyce , Tamir, Sharon Ovnat , Cherches, Alexander D , Din, Taseer , Seguya, Amina , Pandey, Akansha, Nuss, Sarah , Mussa, Carolina Der, Fagan, Johannes J. , Smith, Emily R. , Zalaquett, Nader , Initiative, Global OHNS

Mayo Clinic

Laryngoscope Investigative Otolaryngology | February 14, 2025 | Volume: 10 | Issue: 1 | Pages: No page available

10.1002/lio2.70078 | PMID 39958942 Get It

ABSTRACT Objective Availability of surgical equipment and access to essential clinical services remains an important barrier to surgical care delivery, particularly in low‐ and middle‐income countries (LMICs). This study aims to characterize the relative availability of essential equipment for otolaryngology‐head and neck surgery (OHNS) care across World Bank income groups. Methods We conducted a cross‐sectional survey on otolaryngologists' perceptions on the availability of surgical equipment and ancillary services in their respective practice settings per a 5‐point Likert scale ranging from never to always available. The study was disseminated online via professional societies, personal contacts, and social media. Eligible participants included otolaryngologists from 194 WHO‐recognized countries, which were grouped by World Bank income group classification and WHO region. Results The study involved 146 otolaryngologists, 69 (47%) from high‐income countries (HICs), and 77 (53%) from LMICs. LMIC respondents were predominantly from the African and South‐East Asian regions, which comprised 48% and 7.8% of all LMIC respondents, respectively. Results revealed significant differences in the availability of otologic, rhinologic, and endoscopic airway equipment between HICs and LMICs. Differences existed among commonly used equipment such as tympanomastoidectomy equipment and rigid bronchoscopy, to subspecialized equipment such as functional endoscopic sinus surgery equipment and cochlear implants ( p < 0.05 each). Conclusions The study highlighted key disparities in the availability of essential equipment for baseline OHNS care, especially for pediatric airway and otologic conditions. These results can be used to guide investment and advocacy efforts to improve specialty‐specific surgical infrastructure relative to the global burden of OHNS diseases in low‐resource settings. Level of Evidence 3
Family Medicine Residency Faculty: Inpatient Staffing, Satisfaction, and Turnover
Furlano, Anthony, Nordin, Terri , Ruppel, Lindsey M., Smith, Emily R, Furlano, Anthony J, Hidaka, Brandon H. , Smith, Emily R., Waheed, Abdul A

Mayo Clinic

Family Medicine | February 5, 2025 | Volume: 57 | Issue: 4 | Pages: 276-285

10.22454/fammed.2025.822335 | PMID 40272870 Get It

Background and Objectives: Physician scheduling affects job satisfaction and retention. This study explores how family medicine residency inpatient staffing relates to core faculty retention and program director (PD) perception of faculty satisfaction with work-life integration. Methods: A total of 280 family medicine residency PDs responded to the 2023 Council of Academic Family Medicine Education Research Alliance survey. We used the ꭓ2 test to explore associations among program demographics, inpatient staffing characteristics, faculty retention, and PD-reported faculty satisfaction with work-life integration. We measured associations among pairs of ordinal variables with Spearman’s correlation. Results: In two-thirds (66%) of programs, faculty cover the inpatient service at least every 8 weeks, with 40% of programs reporting averages of 70 or more hours per inpatient week; nevertheless, most programs’ faculty were perceived to be satisfied with less than 10% turnover. The number of hours per week was inversely associated with PD-reported faculty satisfaction (r=-0.21, P=.001). Faculty turnover was directly associated with community size (r=0.17, P=.01). Faculty turnover was more likely to be greater than 10% if the number of hours per inpatient week was more than 89 (odds ratio 12.4, P=.02). Faculty turnover, PD-reported faculty dissatisfaction, and plans to change inpatient staffing were all correlated (r&gt;0.28, P&lt;.0001). Conclusions: Most family medicine residencies have core faculty cover the inpatient service at least once every 8 weeks, during which they work at least 60 hours per week. Longer hours are associated with lower perceived faculty satisfaction of work-life integration, with a threshold effect on faculty turnover. Family medicine residency programs must carefully balance the needs of residents, the community served, and faculty themselves.
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits
Dragojevic, Sonja , Smith, Emily J. , Regan, Michael S. , Stopka, Sylwia A. , Baquer, Gerard , Xue, Zhiyi , Connors, Margaret A. , Kloeber, Jake A. , Hu, Zeng , Ott, Lauren L. , Carlson, Brett L. , Decker, Paul A. , Tian, Shulan , Laverty, Daniel J. , Eckel‐Passow, Jeanette E. , Elmquist, William F. , Agar, Nathalie Y.R. , Callaghan, Cameron M. , Zhang, Wenjuan , Connors, Margaret A , Kloeber, Jake A , Hu, Zeng , Bakken, Katrina K , Ott, Lauren L , Carlson, Brett L , Burgenske, Danielle M , Decker, Paul A. , Tian, Shulan , Gupta, Shiv K , Laverty, Daniel J , Eckel-Passow, Jeanette E , Elmquist, William F , Agar, Nathalie Y R , Nagel, Zachary D , Sarkaria, Jann N , Callaghan, Cameron M , Stopka, Sylwia A , Baquer, Gerard , Regan, Michael S , Zhang, Wenjuan , Bakken, Katrina K. , Burgenske, Danielle M. , Gupta, Shiv K. , Sarkaria, Jann N.

Mayo Clinic

Molecular Cancer Therapeutics | October 23, 2024 | Volume: 24 | Issue: 6 | Pages: 859-869

10.1158/1535-7163.mct-24-0003 | PMID 39440433 Get It

Abstract Glioblastoma (GBM) remains one of the most therapy-resistant malignancies with frequent local failures despite aggressive surgery, chemotherapy, and ionizing radiation (IR). Small molecule inhibitors of DNA-dependent protein kinase (DNA-PKi) are potent radiosensitizers currently in clinical trials. Determining which patients may benefit from radiosensitization with DNA-PKi is critical to avoid unnecessary increased risk of normal tissue toxicity. In this study, we used GBM patient-derived xenografts (PDX) in orthotopic murine models to study the relationship between molecular features, pharmacokinetics, and the radiosensitizing potential of the DNA-PKi peposertib. We show that peposertib radiosensitizes established and PDX GBM lines in vitro at 300 nmol/L and above, with a significant increase in radiosensitization by maintaining post-IR exposure for &gt;12 hours. Radiosensitization by peposertib is mediated by catalytic inhibition of DNA-PK, and knockdown of DNA-PK by short hairpin RNA (shRNA) largely abolished the radiosensitizing effect. Peposertib decreased auto-phosphorylation of DNA-PKcs after IR in a dose-dependent manner with a delay in resolution of γH2AX foci at 24 hours. The addition of peposertib to IR significantly increased survival in GBM120 orthotopic xenografts, but not in GBM10. There was no difference in plasma or average tumor concentrations of peposertib in the two cohorts. Although the mechanism underpinning this discordant effect in vitro versus in vivo is not clear, there was an association for greater sensitization in TP53 mutant lines. Transfection of a dominant-negative TP53 mutant in baseline TP53 wild-type GBM lines significantly delayed growth and decreased nonhomologous end joining efficiency (but not homologous recombination), after peposertib exposure. See related commentary by Buchsbaum, p. 840
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
Johnson, Douglas B. , Albertini, Mark R. , Barker, Christopher A. , Bateni, Sarah B. , Baumgartner, Joel , Bichakjian, Christopher K. , Chandra, Sunandana , DiMaio, Dominick J. , Dronca, Roxana , Fleming, Martin D. , Galan, Anjela , Guild, Samantha, Hyngstrom, John , Karakousis, Giorgos C. , Kendra, Kari , Lange, Julie R., Lanning, Ryan M. , Logan, Theodore F. , Ott, Patrick A. , Ross, Merrick I. , Skitzki, Joseph J. , Smith, Emily , Tsai, Katy K., Wuthrick, Evan , Xing, Yan, McMillian, Nicole R., Espinosa, Sara, Olson, Daniel J. , Swetter, Susan M. , Bhatia, Shailender , Boland, Genevieve M. , Chmielowski, Bartosz , Fields, Ryan C. , Kiuru, Maija H. , Olson, Daniel, Olszanski, Anthony J. , Rothermel, Luke D. , Salama, April K.S. , Sharma, Rohit R. , Xing, Yan

Mayo Clinic

Journal of the National Comprehensive Cancer Network | July 26, 2024 | Volume: 22 | Issue: 5 | Pages: 290-298

10.6004/jnccn.2024.0036 | PMID 39019054 Get It

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous ) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
Ji, Jianxiong , Dragojevic, Sonja , Callaghan, Cameron M. , Smith, Emily J. , Talele, Surabhi , Connors, Margaret A. , Mladek, Ann C. , Hu, Zeng , Bakken, Katrina K. , Sarkaria, Paige P., Carlson, Brett L. , Decker, Paul A. , Rashid, Mohammad Abdur , Jang, Mi‐Hyeon , Eckel‐Passow, Jeanette E. , Elmquist, William F. , Zhang, Wenjuan , Connors, Margaret A , Mladek, Ann C , Hu, Zeng , Bakken, Katrina K , Sarkaria, Paige P , Carlson, Brett L , Burgenske, Danielle M , Decker, Paul A. , Rashid, Mohammad Abdur , Jang, Mi-Hyeon , Gupta, Shiv K , Eckel-Passow, Jeanette E , Elmquist, William F , Sarkaria, Jann N , Talele, Surabhi , Callaghan, Cameron M , Zhang, Wenjuan , Burgenske, Danielle M. , Gupta, Shiv K. , Sarkaria, Jann N.

Mayo Clinic

Molecular Cancer Therapeutics | January 22, 2024 | Volume: 23 | Issue: 5 | Pages: 662-671

10.1158/1535-7163.mct-23-0552 | PMID 38224566 Get It

Abstract Radioresistance of melanoma brain metastases limits the clinical utility of conventionally fractionated brain radiation in this disease, and strategies to improve radiation response could have significant clinical impact. The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is critical for repair of radiation-induced DNA damage, and inhibitors of this kinase can have potent effects on radiation sensitivity. In this study, the radiosensitizing effects of the DNA-PKcs inhibitor peposertib were evaluated in patient-derived xenografts of melanoma brain metastases (M12, M15, M27). In clonogenic survival assays, peposertib augmented radiation-induced killing of M12 cells at concentrations ≥100 nmol/L, and a minimum of 16 hours exposure allowed maximal sensitization. This information was integrated with pharmacokinetic modeling to define an optimal dosing regimen for peposertib of 125 mpk dosed just prior to and 7 hours after irradiation. Using this drug dosing regimen in combination with 2.5 Gy × 5 fractions of radiation, significant prolongation in median survival was observed in M12-eGFP (104%; P = 0.0015) and M15 (50%; P = 0.03), while more limited effects were seen in M27 (16%, P = 0.04). These data support the concept of developing peposertib as a radiosensitizer for brain metastases and provide a paradigm for integrating in vitro and pharmacokinetic data to define an optimal radiosensitizing regimen for potent DNA repair inhibitors.
Pediatric Chemotherapy Infusions in Outpatient Examination Rooms: A Novel Patient Care Approach
Omdahl, Tami K., Stenzel, Janelle L., Pike, Marsha L., Conlon, Patricia M. , Barry, Tracy A., Brown, Tanya M. , Cambern, Kari L., Davis, Kadi M., Fjerstad, Kelly A., Graner, Kevin, Larson, Alison P., Soefje, Scott A. , Janssen, Alan M., Graner, Kevin K, Kuhn, Alexis K , Orandi, Amir B , Smith, Emily L., Soefje, Scott A , Omdahl, Tami K, Kuhn, Alexis , Orandi, Amir B. , Smith, Emily L.

Mayo Clinic

Journal of Pediatric Hematology/Oncology Nursing | February 13, 2023 | Volume: 40 | Issue: 3 | Pages: 195-202

10.1177/27527530221140067 | PMID 36775936 Get It

Background: Many health care organizations offer pediatric infusions in outpatient infusion centers or, as in our organization, in a hospital-based outpatient Pediatric Infusion Therapy Center (PITC). When restrictions related to the COVID-19 pandemic decreased our PITC appointment capacity by 40%, other patient and family satisfaction issues were exacerbated. We implemented a new approach to pediatric infusions with the aim of improving patient and family satisfaction and reducing the amount of time in an appointment itinerary without negatively affecting patient safety. Methods: Our team used a phased approach to pilot the administration of short chemotherapy infusions in the same outpatient clinic examination rooms where consultation and routine office visits were conducted. Patients saw their specialist for an examination and, if clinically indicated, their infusion was administered in the same room. Appointment itineraries were then completed. The team tracked efficiency, satisfaction, and safety metrics related to the new process. Results: All efficiency metrics improved. No harm came to the 49 unique patients who received a total of 184 infusions. Patient appointment itineraries were shortened by an average of 1.03 hr. Satisfaction survey responses indicated a clear preference (93%) for the new process. Discussion: The novel approach of offering short infusions in outpatient clinic examination rooms provides an opportunity to ease capacity constraints and further increase patient and family satisfaction. This method may be especially helpful for health care organizations when external influences (e.g., lack of physical space, challenging patient volumes, and pandemics) necessitate a change.
The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome
Herndon, Justine , Kaur, Ravinder Jeet , Romportl, Mark, Smith, Emily, Koenigs, Amy, Partlow, Brenda, Arteaga, Leonardo, Bancos, Irina , Smith, Emily, Bancos, Irina

Mayo Clinic

Journal of the Endocrine Society | December 5, 2021 | Volume: 6 | Issue: 1 | Pages: No page available

10.1210/jendso/bvab169 | PMID 34988348 Get It

Abstract Context Hyperglycemia is a common complication of Cushing syndrome (CS). Objective We aimed to determine the impact of curative procedure on hyperglycemia and its management in patients with CS. Methods This retrospective longitudinal cohort study took place 2000 to 2019 in a referral center among adults with endogenous CS and hyperglycemia. Main outcome measures included glycated hemoglobin A1c (HbA1c), intensity of hyperglycemia therapy, and improvement of hyperglycemia. Results In 174 patients with CS (pituitary in 106, ectopic in 25, adrenal in 43), baseline median HbA1c was 6.9% (range, 4.9-13.1), with 41 (24%) patients not on any therapy for hyperglycemia, 93 (52%) on oral medications, and 64 (37%) on insulin (median daily units of 58; range, 10-360). Following CS remission, at the end of follow-up (median 10.5 months), 37 (21%) patients demonstrated resolution of hyperglycemia, 82 (47%) demonstrated improvement, and 55 (32%) had no change or worsening in hyperglycemia. At the end of follow-up, HbA1c decreased by 0.84% (P &lt; .001) and daily insulin dose decreased by a mean of 30 units (P &lt; .001). Biochemical hypercortisolism severity score (severe vs moderate/mild: odds ratio [OR] of 2.4 [95% CI, 1.1-4.9]), and CS subtype (nonadrenal vs adrenal: OR of 2.9 [95% CI, 1.3-6.4]), but not type of hyperglycemia (diabetes vs prediabetes: OR of 2.1 [0.9-4.9]) were associated with hyperglycemia improvement at the end of follow-up. Conclusion Two-thirds of patients with CS and hyperglycemia demonstrate resolution or improvement of hyperglycemia after a curative procedure. Close monitoring during CS recovery is needed to ensure appropriate therapy modification.
EXTH-01. INHIBITION OF DNA-PKcs BY M3814 POTENTIATES EFFICACY OF IONIZING RADIATION IN PATIENT-DERIVED XENOGRAFTS OF MELANOMA BRAIN METASTASES
Ji, Jianxiong , Sarkaria, Paige P., Swanson, Katelyn, Mohammad, Afroz S., He, Lihong , Hu, Zeng , Zhao, Yu , Connors, Margaret A. , Porath, Kendra A. , Carlson, Brett L. , Kitange, Gaspar J. , Elmquist, William F. , Smith, Emily J. , Mladek, Ann C. , Talele, Surabhi , Zhang, Wenjuan , Chen, Jiajia , Bakken, Katrina K. , Dragojevic, Sonja , Gupta, Shiv K. , Burgenske, Danielle M. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | December 4, 2020 | Volume: 22 | Issue: Supplement_2 | Pages: ii86-ii86

10.1093/neuonc/noaa215.355 Get It

Abstract Radio-resistance mechanisms limit the benefit of radiation therapy (RT) for melanoma brain metastases. A key pathway for radiation-induced DNA double-strand break repair is non-homologous end joining, which is critically mediated by DNA-dependent protein kinase (DNA-PKcs). Here we evaluated radio-sensitizing effects of M3814, a selective oral inhibitor of DNA-PKcs, in patient-derived xenografts (PDXs) of melanoma brain metastases. In a clonogenic survival assay, M3841 augmented RT-induced killing of M12 cells at concentrations of ≥300 nM, and a minimum of 16 h exposure with ~300 nM M3814 was required for effective sensitization. M3814 inhibited RT-induced (5 Gy) auto-phosphorylation of serine-2056 of DNA-PKcs in primary cultures of M12, M15 and M27 PDX lines. Interestingly, inhibition of RT-induced DNA-PKcs by M3814 coincided with increased KAP1 phosphorylation, a DNA damage signaling regulated via ATM. Persistent γH2AX foci were observed in 28% M12 cells at 24 hours after co-treatment with M3814 and RT as compared to 12% cells following RT alone. In vivo pharmacokinetic analysis after single oral dose of 20 mg/kg M3814, showed reasonably short half-life (~2.44 hours) and poor brain distribution in wild-type FBV mice (Kpuu, 0.027). Consistent with an efflux liability, brain distribution of M3814 in triple knockout mice for BCRP/MDR1A/B was ~11 fold higher (Kpuu, 0.215). Compared to normal brain, much higher M3814 concentrations were detected in intracranially implanted M12 tumors (~23 fold and ~20 fold) 2 and 6 hours after a single oral dose of 50mg/kg respectively. The relative exclusion of M3814 from normal brain as compared to brain metastases suggests that this drug may have a favorable toxicity profile when combined with radiation for treatment of melanoma brain metastases, and this hypothesis is being tested in ongoing efficacy studies.